High-Definition Erenna® Immunoassay System
The Erenna Immunoassay System, powered by Singulex's patented single-molecule detection technology, accelerates biomedical and translational research by accurately and reliably quantifying low-abundance biomarkers at or below sub-picogram concentrations. This unique high-definition technology enables distinct stratification of healthy and disease subjects through a broad dynamic range of over 4 logs, enhancing the clinical uti…
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Singulex bead based immunoassay system can give 10 fold higher sensitivity than MSD platform, but the platform is not robust and reproducibility is a problem.
Review Date: 26 Nov 2014 | Merck
The Erenna Immunoassay System, powered by Singulex's patented single-molecule detection technology, accelerates biomedical and translational research by accurately and reliably quantifying low-abundance biomarkers at or below sub-picogram concentrations. This unique high-definition technology enables distinct stratification of healthy and disease subjects through a broad dynamic range of over 4 logs, enhancing the clinical utility of biomarkers and allowing researchers to gain insights into drug safety and efficacy.
The Erenna Immunoassay System includes fully equipped benchtop analytical instrumentation, integrated and prepared reagents for ultrasensitive immunoassays, and dedicated software to automatically analyze data and display detailed assay reports.
The Erenna Immunoassay System uses a robust digital molecule-counting module to count photons, where ultra-sensitive fluorescence is measured in the presence of proprietary background reduction methodology. A large dynamic range of 4+ logs is obtained by combining single-molecule counting (low range) with photon counting (mid range) and total light measurements (high range).
Brochures
SMCxPRO Immunoassay System: Sensitivity You Can Count On
Your research demands flexibility to move from platform to platform and assay to assay. Using single molecule counting (SMC™) technology, MilliporeSigma offers you the ability to take the analysis of your protein of interest down to femtogram/mL levels using the ultrasensitive protein detection SMCxPRO™ platform. This improved level of sensitivity allows for previously undetectable proteins to now be quantified, including endogenous levels.
Bring Your Biomarkers to Life
Discover the protein detection system that fits your needs.
Reput(Ab)le Cancer-Signaling Antibodies
We’re validated. We’re guaranteed. We’re published. We create the antibodies most cited by the research community. Recognizing both the tremendous opportunities and the challenges facing cancer researchers, EMD Millipore is dedicated to developing and refining tools and technologies for the study of cancer. With EMD Millipore’s comprehensive portfolio of reagents and antibodies, researchers can count on dependable, high-quality solutions for analyzing all the hallmarks of cancer.
Microfluidic Perfusion Enables Long-Term Cell Culture, Precise Microenvironment Control and Gene Expression Analysis
In this application note the M04S Microfluidic Plate and CellASIC® ONIX Microfluidic System are used to demonstrate long-term culture of adherent cells, to create dynamic solution profiles (media switching and spatial gradient), to immunostain cells within the microfluidic chamber, and to analyze gene expression.
Improved Performance with Conversion from ELISA to an Erenna® Immunoassay
This application note from EMD Millipore demonstrates the Erenna Immunoassay System as a system to quantify a target that using an ELISA technique was undetectable. The application note looks at benefits of different techniques to decide which technique is best for results and cost effective.
Cardiotoxicity: Elevations of Cardiac Troponin-I Quantified with the Erenna cTnl Immunoassay
In this application note, cTnl measured by the Erenna® Immunoassay System, from Singulex, was more sensitive than histopathology and other clinical platforms currently available to identify acute cardiotoxicity. The potential of the Erenna cTnl assay for improving the safety profiles of candidate drugs is also demonstrated.
The Latest Cell Biology News, Techniques and Technology
Discover the most exciting new developments in cell biology research this month
